Loading...
Loading...
SNN| Name | Value |
|---|---|
| Revenues | 2,792.6M |
| Cost of Revenue | 886.9M |
| Gross Profit | 1,905.7M |
| Operating Expense | 1,461.3M |
| Operating I/L | 444.4M |
| Other Income/Expense | -356.1M |
| Interest Income | 15.9M |
| Pretax | 88.3M |
| Income Tax Expense | -11.9M |
| Net Income/Loss | 90.3M |
Smith & Nephew plc develops, manufactures, and sells a wide range of medical devices worldwide. Its products include knee and hip implants for joint reconstruction, trauma and extremities devices for fracture stabilization, sports medicine products for minimally invasive joint surgery, arthroscopic enabling technologies, and ear, nose, and throat solutions. The company also offers advanced wound care products for acute and chronic wounds, including bioactives and regenerative medicine products, as well as advanced wound devices such as negative pressure wound therapy systems. Smith & Nephew primarily serves healthcare providers, generating revenue through the sale of its medical devices and wound care products.
